238 related articles for article (PubMed ID: 1384316)
1. Human Lyb-2 homolog CD72 is a marker for progenitor B-cell leukemias.
Schwarting R; Castello R; Moldenhauer G; Pezzutto A; von Hoegen I; Ludwig WD; Parnes JR; Dörken B
Am J Hematol; 1992 Nov; 41(3):151-8. PubMed ID: 1384316
[TBL] [Abstract][Full Text] [Related]
2. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells.
Uckun FM; Gajl-Peczalska K; Myers DE; Jaszcz W; Haissig S; Ledbetter JA
Blood; 1990 Dec; 76(12):2449-56. PubMed ID: 1702326
[TBL] [Abstract][Full Text] [Related]
3. Biochemical identity of the mouse Ly-19.2 and Ly-32.2 alloantigens with the B cell differentiation antigen Lyb-2/CD72.
Robinson WH; Landolfi MM; Schäfer H; Parnes JR
J Immunol; 1993 Nov; 151(9):4764-72. PubMed ID: 8409435
[TBL] [Abstract][Full Text] [Related]
4. Selective response of CD5+ B cell malignancies to activation of the CD72 antigen.
Planken EV; Van de Velde H; Falkenburg JH; Thielemans K; Willemze R; Kluin-Nelemans JC
Clin Immunol Immunopathol; 1998 Apr; 87(1):42-9. PubMed ID: 9576009
[TBL] [Abstract][Full Text] [Related]
5. MY4 expression on B-lymphocyte malignancies may be associated with a more adverse prognosis.
Warzynski MJ; Otto RN; Steingart RH; White CF; Rosen MH; Hetzel PC; Flatow FA; Podgurski AE; Johnson ML
Leuk Res; 1991; 15(5):357-65. PubMed ID: 2046387
[TBL] [Abstract][Full Text] [Related]
6. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
7. Identity of human Lyb-2 and CD72 and localization of the gene to chromosome 9.
Von Hoegen I; Hsieh CL; Scharting R; Francke U; Parnes JR
Eur J Immunol; 1991 Jun; 21(6):1425-31. PubMed ID: 2044654
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody NU-B1 reacts with novel antigen on human B cells in mantle and marginal zones distinct from known CD molecules.
Matsuo Y; Sugimoto A; Kuwahara K; Watanabe Y; Sakata A; Sakaguchi N; Sagawa K; Orita K
Tissue Antigens; 1998 Nov; 52(5):422-9. PubMed ID: 9864031
[TBL] [Abstract][Full Text] [Related]
10. Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three-color immunocytometry.
Segal GH; Edinger MG; Owen M; McNealis M; Lopez P; Perkins A; Linden MD; Fishleder AJ; Stoler MH; Tubbs RR
Cytometry; 1991; 12(4):350-9. PubMed ID: 1712263
[TBL] [Abstract][Full Text] [Related]
11. An anti-CD72 immunotoxin against therapy-refractory B-lineage acute lymphoblastic leukemia.
Myers DE; Uckun FM
Leuk Lymphoma; 1995 Jun; 18(1-2):119-22. PubMed ID: 8580813
[TBL] [Abstract][Full Text] [Related]
12. CD1c but neither CD1a nor CD1b molecules are expressed on normal, activated, and malignant human B cells: identification of a new B-cell subset.
Delia D; Cattoretti G; Polli N; Fontanella E; Aiello A; Giardini R; Rilke F; Della Porta G
Blood; 1988 Jul; 72(1):241-7. PubMed ID: 3260523
[TBL] [Abstract][Full Text] [Related]
13. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
14. The value of the monoclonal antibody, DBA44, in the diagnosis of B-lymphoid disorders.
Salomon-Nguyen F; Valensi F; Troussard X; Flandrin G
Leuk Res; 1996; 20(11-12):909-13. PubMed ID: 9009248
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of B lymphocytes via CD72 (human Lyb-2).
Kamal M; Katira A; Gordon J
Eur J Immunol; 1991 Jun; 21(6):1419-24. PubMed ID: 1828426
[TBL] [Abstract][Full Text] [Related]
16. "Small" B-cell non-Hodgkin's lymphomas with splenomegaly at presentation are either mantle cell lymphoma or marginal zone cell lymphoma. A study based on histology, cytology, immunohistochemistry, and cytogenetic analysis.
Pittaluga S; Verhoef G; Criel A; Wlodarska I; Dierlamm J; Mecucci C; Van den Berghe H; De Wolf-Peeters C
Am J Surg Pathol; 1996 Feb; 20(2):211-23. PubMed ID: 8554111
[TBL] [Abstract][Full Text] [Related]
17. G protein subunit G alpha 16 expression is restricted to progenitor B cells during human B-cell differentiation.
Mapara MY; Bommert K; Bargou RC; Leng C; Beck C; Ludwig WD; Gierschik P; Dörken B
Blood; 1995 Apr; 85(7):1836-42. PubMed ID: 7703490
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a monoclonal antibody directed against Gb3Cer/CD77: a useful immunochemical reagent for a differentiation marker in Burkitt's lymphoma and germinal centre B cells.
Miyamoto D; Ueno T; Takashima S; Ohta K; Miyawaki T; Suzuki T; Suzuki Y
Glycoconj J; 1997 Apr; 14(3):379-88. PubMed ID: 9147061
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow involvement in non-Hodgkin's lymphoma: increased diagnostic sensitivity by combination of immunocytology, cytomorphology and trephine histology.
Schwonzen M; Pohl C; Steinmetz T; Wickramanayake PD; Thiele J; Diehl V
Br J Haematol; 1992 Jul; 81(3):362-9. PubMed ID: 1382545
[TBL] [Abstract][Full Text] [Related]
20. CD2 is expressed by a subpopulation of normal B cells and is frequently present in mature B-cell neoplasms.
Kingma DW; Imus P; Xie XY; Jasper G; Sorbara L; Stewart C; Stetler-Stevenson M
Cytometry; 2002 Oct; 50(5):243-8. PubMed ID: 12360573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
